Literature DB >> 16286589

Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study.

Ignatios Ikonomidis1, George Athanassopoulos, John Lekakis, Kyriaki Venetsanou, Margarita Marinou, Kimon Stamatelopoulos, Dennis V Cokkinos, Petros Nihoyannopoulos.   

Abstract

BACKGROUND: Interleukin-6 (IL-6) and macrophage colony stimulating factor plasma levels are elevated in acute coronary syndromes. IL-6 has an inherent negative inotropic action and, with tissue factor (TF), mediates the ischemia-reperfusion myocardial injury. We hypothesized that inducible ischemia leads to cytokine production, TF expression, and consequently persistent left ventricular dysfunction after dobutamine stress echocardiography (DSE) in coronary artery disease patients. METHODS AND
RESULTS: DSE was performed in 103 patients with angiographically documented coronary artery disease. Blood samples were obtained at rest, at peak stress, and 30 minutes after cessation of dobutamine infusion for measurement of macrophage colony stimulating factor, IL-6, and TF. New or worsening wall motion abnormalities at peak stress and their duration into recovery were noted. Median IL-6 and TF levels were increased at peak stress and at 30 minutes into recovery compared with rest (2.7 and 2.4 versus 2.1 pg/mL for IL-6, 310 and 385 versus 266 pg/mL for TF [P<0.01] in patients with an ischemic response; n=55). Compared with rest, a greater release of IL-6 at peak stress and recovery was observed in patients with increasing number of ischemic segments at peak DSE (2 versus 3 to 4 versus 5 to 6 versus 7 to 8 segments; P=0.03). The time to recovery of wall motion abnormalities was also associated with IL-6 levels at peak stress and recovery (r=0.51 and r=0.39, P<0.05). Macrophage colony stimulating factor levels remained unchanged throughout DSE.
CONCLUSIONS: Reversible ischemia induced during DSE increases IL-6 and TF plasma levels. IL-6 is related to the extent of left ventricular dysfunction at peak stress and to persistent LV dysfunction during recovery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286589     DOI: 10.1161/CIRCULATIONAHA.104.532259

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 2.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

3.  Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.

Authors:  Ignatios Ikonomidis; George Pavlidis; Pelagia Katsimbri; Ioanna Andreadou; Helen Triantafyllidi; Maria Tsoumani; Maria Varoudi; Dimitrios Vlastos; George Makavos; Gavriella Kostelli; Dimitrios Βenas; John Lekakis; John Parissis; Dimitrios Boumpas; Dimitrios Alexopoulos; Efstathios Iliodromitis
Journal:  Clin Res Cardiol       Date:  2019-03-11       Impact factor: 5.460

Review 4.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

5.  Therapeutic regulation of systemic inflammation in xenograft recipients.

Authors:  Hayato Iwase; Hong Liu; Tao Li; Zhongquiang Zhang; Bingsi Gao; Hidetaka Hara; Martin Wijkstrom; Cassandra Long; Ryan Saari; David Ayares; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2017-03-12       Impact factor: 3.907

6.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05

7.  Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography.

Authors:  Nowell M Fine; Cynthia S Crowson; Grace Lin; Jae K Oh; Hector R Villarraga; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 8.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

9.  Inflammatory response to mental stress and mental stress induced myocardial ischemia.

Authors:  Muhammad Hammadah; Samaah Sullivan; Brad Pearce; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Samman Tahhan; Wesley T O'Neal; Malik Obideen; Ayman Alkhoder; Naser Abdelhadi; Heval Mohamed Kelli; Mohamad Mazen Ghafeer; Pratik Pimple; Pratik Sandesara; Amit J Shah; Kareem Mohammed Hosny; Laura Ward; Yi-An Ko; Yan V Sun; Lei Weng; Michael Kutner; J Douglas Bremner; David S Sheps; Fabio Esteves; Paolo Raggi; Viola Vaccarino; Arshed A Quyyumi
Journal:  Brain Behav Immun       Date:  2017-10-03       Impact factor: 7.217

Review 10.  Cardiac xenotransplantation: a promising way to treat advanced heart failure.

Authors:  Songren Shu; Jie Ren; Jiangping Song
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.